Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer-Reference-Cited by-同舟云学术

Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer

Published:2007-02-17 Issue:6 Volume:60 Page:811-819
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Yong Wei Peng,Desai Apurva A.,Innocenti Federico,Ramirez Jacqueline,Shepard Dale,Kobayashi Ken,House Larry,Fleming Gini F.,Vogelzang Nicholas J.,Schilsky Richard L.,Ratain Mark J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-007-0428-5.pdf

Reference52 articles.

1. Ahmed FY, Johnston SJ, Cassidy J, O’Kelly T, Binnie N, Murray GI, van Gennip AH, Abeling NG, Knight S, McLeod HL (1999) Eniluracil treatment completely inactivates dihydropyrimidine dehydrogenase in colorectal tumors. J Clin Oncol 17:2439–2445

2. Aita P, Robieux I, Sorio R, Tumolo S, Corona G, Cannizzaro R, Colussi AM, Boiocchi M, Toffoli G (1999) Pharmacokinetics of oral etoposide in patients with hepatocellular carcinoma. Cancer Chemother Pharmacol 43:287–294

3. Ando Y, Saka H, Asai G, Sugiura S, Shimokata K, Kamataki T (1998) UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan. Ann Oncol 9:845–847

4. Arbuck SG, Douglass HO, Crom WR, Goodwin P, Silk Y, Cooper C, Evans WE (1986) Etoposide pharmacokinetics in patients with normal and abnormal organ function. J Clin Oncol 4:1690–1695

5. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, Oude Elferink RP, Chowdhury NR (1995) The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome. N Engl J Med 333:1171–1175

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics–Pharmacodynamics Modeling for Evaluating Drug–Drug Interactions in Polypharmacy: Development and Challenges;Clinical Pharmacokinetics;2024-06-18

2. Recommendations on the use of azole antifungals in hematology-oncology patients;Revista Española de Quimioterapia;2023-04-05

3. Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma;Journal of Clinical Medicine;2022-12-01

4. Boosting the oral bioavailability of anticancer drugs through intentional drug–drug interactions;Basic & Clinical Pharmacology & Toxicology;2021-06-28

5. Metabolism-based Drug-drug Interactions in Patients with Chronic Respiratory Diseases: A Review Focusing on Drugs Affecting the Respiratory System;Current Drug Metabolism;2020-12-14